Literature DB >> 2244882

Interleukin-1 beta prevents the stimulatory effect of transforming growth factor-beta on collagen gene expression in human skin fibroblasts.

J Heino1, T Heinonen.   

Abstract

Transforming growth factors beta 1 and beta 2 (TGF-beta 1 and TGF-beta 2) are well-characterized strong inducers of collagen gene expression. A 100 pM concentration of TGF-beta 1 or TGF-beta 2 increases pro alpha 1(I) collagen mRNA levels in human skin fibroblasts 6.6-fold and 7.0-fold respectively, and also increases the accumulation of procollagens in the cell culture medium. Interleukin-1 beta (IL-1 beta) is an inflammatory mediator which also regulates connective tissue metabolism. A small concentration of IL-1 beta (0.01-1.0 unit/ml) slightly increases pro alpha 1(I) collagen mRNA levels (2.2-fold). Here we provide evidence that IL-1 beta prevents the stimulatory effect of TGFs-beta on collagen synthesis in human skin fibroblasts. An IL-1 beta concentration of 1 unit/ml is enough to keep pro alpha 1(I) collagen mRNA levels at control values in cells stimulated by 100 pM-TGF-beta 1. Thus the results indicate that IL-1 beta inhibits collagen synthesis in cells activated by TGFs-beta, whereas it does not significantly change or might even stimulate collagen gene expression in non-activated cells.

Entities:  

Mesh:

Substances:

Year:  1990        PMID: 2244882      PMCID: PMC1149639          DOI: 10.1042/bj2710827

Source DB:  PubMed          Journal:  Biochem J        ISSN: 0264-6021            Impact factor:   3.857


  43 in total

1.  Regulation of cell adhesion receptors by transforming growth factor-beta. Regulation of vitronectin receptor and LFA-1.

Authors:  R A Ignotz; J Heino; J Massagué
Journal:  J Biol Chem       Date:  1989-01-05       Impact factor: 5.157

2.  A nuclear factor 1 binding site mediates the transcriptional activation of a type I collagen promoter by transforming growth factor-beta.

Authors:  P Rossi; G Karsenty; A B Roberts; N S Roche; M B Sporn; B de Crombrugghe
Journal:  Cell       Date:  1988-02-12       Impact factor: 41.582

3.  Interleukin-1 alpha modulates collagen gene expression in cultured synovial cells.

Authors:  A Mauviel; L Teyton; R Bhatnagar; H Penfornis; M Laurent; D Hartmann; J Bonaventure; G Loyau; J Saklatvala; J P Pujol
Journal:  Biochem J       Date:  1988-05-15       Impact factor: 3.857

4.  Differential regulation of collagen, glycosaminoglycan, fibronectin, and collagenase activity production in cultured human adult dermal fibroblasts by interleukin 1-alpha and beta and tumor necrosis factor-alpha and beta.

Authors:  M R Duncan; B Berman
Journal:  J Invest Dermatol       Date:  1989-05       Impact factor: 8.551

5.  Human recombinant interleukin-1 regulates cellular mRNA levels of dermatan sulphate proteoglycan core protein.

Authors:  J Heino; V M Kähäri; A Mauviel; T Krusius
Journal:  Biochem J       Date:  1988-05-15       Impact factor: 3.857

6.  Transforming growth factor-beta production by synovial tissues from rheumatoid patients and streptococcal cell wall arthritic rats. Studies on secretion by synovial fibroblast-like cells and immunohistologic localization.

Authors:  R Lafyatis; N L Thompson; E F Remmers; K C Flanders; N S Roche; S J Kim; J P Case; M B Sporn; A B Roberts; R L Wilder
Journal:  J Immunol       Date:  1989-08-15       Impact factor: 5.422

7.  Transcriptional regulation of osteopontin production in rat osteosarcoma cells by type beta transforming growth factor.

Authors:  M Noda; K Yoon; C W Prince; W T Butler; G A Rodan
Journal:  J Biol Chem       Date:  1988-09-25       Impact factor: 5.157

8.  Transforming growth factor-beta is a potent inhibitor of IL-1 induced protease activity and cartilage proteoglycan degradation.

Authors:  S Chandrasekhar; A K Harvey
Journal:  Biochem Biophys Res Commun       Date:  1988-12-30       Impact factor: 3.575

9.  Regulation of cell adhesion receptors by transforming growth factor-beta. Concomitant regulation of integrins that share a common beta 1 subunit.

Authors:  J Heino; R A Ignotz; M E Hemler; C Crouse; J Massagué
Journal:  J Biol Chem       Date:  1989-01-05       Impact factor: 5.157

10.  Interleukin 1 stimulation of synovial cell plasminogen activator production.

Authors:  E Mochan; J Uhl; R Newton
Journal:  J Rheumatol       Date:  1986-02       Impact factor: 4.666

View more
  6 in total

1.  Leukoregulin down-regulates type I collagen mRNA levels and promoter activity in human dermal fibroblasts, and counteracts the up-regulation elicited by transforming growth factor-beta.

Authors:  A Mauviel; C H Evans; J Uitto
Journal:  Biochem J       Date:  1992-06-15       Impact factor: 3.857

2.  Anti-Inflammatory and Pro-Regenerative Effects of Hyaluronan-Chitlac Mixture in Human Dermal Fibroblasts: A Skin Ageing Perspective.

Authors:  Alice Donato; Elisa Belluzzi; Elena Mattiuzzo; Rina Venerando; Massimiliano Cadamuro; Pietro Ruggieri; Vincenzo Vindigni; Paola Brun
Journal:  Polymers (Basel)       Date:  2022-04-29       Impact factor: 4.967

3.  Role of transforming growth factor-beta in maintenance of function of cultured neonatal cardiac myocytes. Autocrine action and reversal of damaging effects of interleukin-1.

Authors:  A B Roberts; N S Roche; T S Winokur; J K Burmester; M B Sporn
Journal:  J Clin Invest       Date:  1992-11       Impact factor: 14.808

4.  RNA-sequencing analysis of lung primary fibroblast response to eosinophil-degranulation products predicts downstream effects on inflammation, tissue remodeling and lipid metabolism.

Authors:  Stephane Esnault; Ksenija Bernau; Elizabeth E Torr; Yury A Bochkov; Nizar N Jarjour; Nathan Sandbo
Journal:  Respir Res       Date:  2017-11-10

Review 5.  Evaluation of TGF-β1 and EGFR in Cleft Affected Lip Mucosa.

Authors:  Olga Rimdenoka; Māra Pilmane
Journal:  Acta Med Litu       Date:  2021-03-25

6.  Interleukin-1β attenuates myofibroblast formation and extracellular matrix production in dermal and lung fibroblasts exposed to transforming growth factor-β1.

Authors:  Masum M Mia; Miriam Boersema; Ruud A Bank
Journal:  PLoS One       Date:  2014-03-12       Impact factor: 3.240

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.